The University of Oxford plans to test its vaccine in children for the first time, becoming the latest vaccine developer to assess whether its shot is effective in young people. The trial seeks to recruit 300 volunteers between the ages of 6 and 17, with up to 240 receiving the vaccine and the remainder a control meningitis vaccine. Andrew Pollard, chief researcher on the Oxford vaccine trial, says that while ...